Nearly 93% of the U.S. population lives in a hospital referral region with at least one medical center that performs 25 or more mitral valve repairs or replacements each year, according to work published in JAMA Cardiology—but MVRR centers continue to suffer from significant geographical and patient-level disparities.

A group of researchers in the U.K. reported this week that even slight increases in a person’s cardiac troponin levels predict adverse outcomes—including early death—in patients of all ages.

A study presented at the American Heart Association’s Scientific Sessions in Philadelphia this November found that heart patients who practiced routine intermittent fasting over a period of four and a half years were ultimately healthier than those who didn’t.

People trained to perform CPR with a virtual reality tool were able to achieve comparable chest compression rates as those trained face-to-face in a recent randomized study—but the VR approach still has a long way to go.

Legal loopholes in the 510(k) clearance process mean countless faulty BP devices can make it to pharmacy shelves without proper testing, leading to confusion among consumers and healthcare providers alike, according to a news story from the American Medical Association.

Primary results from the GALILEO trial, presented at the American Heart Association’s annual meeting this November, suggest patients undergoing TAVR with no ongoing indication for oral anticoagulation benefit more from an antiplatelet-based treatment approach than a rivaroxaban-based approach.

Joint research from the American Heart Association and American Medical Association suggests that just half of practicing physicians and healthcare professionals have received blood pressure measurement training since they left school.

Use of the Impella heart pump during PCI rose rapidly between the 2000s and 2010s, according to a Circulation analysis—but so did its variability across hospitals and associated adverse outcomes.